Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Active, not recruiting · NCT01587352 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vorinostat in Treating Patients With Metastatic Melanoma of the Eye | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanoma | Active, not recruiting | Phase 2 | 2026-07-29 | NCT01587352 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut Curie Paris | 1 |
| Memorial Sloan Kettering Cancer Center | 753 |
| Moffitt Cancer Center P2C | 1 |
| National Cancer Institute (NCI) | 3015 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center | New York | United States | 189 |
| Vanderbilt University/Ingram Cancer Center | Nashville | United States | 259 |